Phase III, Randomized, Placebo-controlled, Double-blind, Multi-center, International Study of Durvalumab Following Stereotactic Body Radiation Therapy (SBRT) (PACIFIC-4/RTOG-3515)
Clinical Trial Grant
Awarded By
AstraZeneca Pharmaceuticals, LP
Start Date
January 2, 2020
End Date
March 29, 2022
Awarded By
AstraZeneca Pharmaceuticals, LP
Start Date
January 2, 2020
End Date
March 29, 2022